NIH #R01NS076815
Endocannabinoids in neurodegenerative diseases
Active
- Amount
- $700K–$800K
- Period
- 2012-06-15 → 2028-04-30
- PIs
- 1
Awarded at UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Chen Chu
Full Professor(heuristic)
Prostate Cancer Treatment and Research · Pulmonary and Respiratory Medicine
Compare more Pulmonary and Respiratory Medicine professors.
h-index38
i10-index67
Publications124
Citations18,882
Grants
4 total · 4 active
NIH #R01AG081362
Silencing of astrocytic MAGL as a therapy for Alzheimer’s disease
Active
- Amount
- $700K–$800K
- Period
- 2023-04-15 → 2028-03-31
- PIs
- 1
Awarded at UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
NIH #R01CA273595
Novel regulatory mechanisms and agonists of STING
Active
- Amount
- $600K–$700K
- Period
- 2023-03-01 → 2028-02-29
- PIs
- 3
Awarded at UT SOUTHWESTERN MEDICAL CENTER
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis (Cell Death and Disease)2026-06-27
- New NIH award: Silencing of astrocytic MAGL as a therapy for Alzheimer’s disease2023-04-15
- New NIH award: Novel regulatory mechanisms and agonists of STING2023-03-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0001-8084-0867